TrialPharmaceutical research2017

Development of a Level A in Vitro-in Vivo Correlation for Veliparib (ABT-888) Extended Release Tablet Formulation.

Rajendar K Mittapalli et al.PubMed ↗Publisher ↗

No numbers read from the abstract.